Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
SD Biotechnologies seeks South Korean court injunction to halt KRX delisting decision

SD Biotechnologies seeks South Korean court injunction to halt KRX delisting decision

BitgetBitget2026/10/07 07:01

SD Biotechnologies filed an injunction request with the Seoul Southern District Court to suspend the Korea Exchange’s Oct. 6 delisting decision. The filing seeks to halt the delisting’s effect until a final ruling in the main case. It also asks the court to block the exchange from proceeding with the stock’s liquidation trading process. The court case was accepted on Oct. 7 under docket number 2026Kahap1615. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SD Biotechnologies Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261007900331), on October 07, 2026, and is solely responsible for the information contained therein.

  • SD Biotechnologies filed an injunction request with the Seoul Southern District Court to suspend the Korea Exchange’s Oct. 6 delisting decision.
  • The filing seeks to halt the delisting’s effect until a final ruling in the main case.
  • It also asks the court to block the exchange from proceeding with the stock’s liquidation trading process.
  • The court case was accepted on Oct. 7 under docket number 2026Kahap1615.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SD Biotechnologies Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261007900331), on October 07, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output

Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.

智通财经•2026/11/10 04:12

Bank of Japan minutes turn hawkish: Most members believe a rate hike is needed soon, with a 70% probability of a hike in December

Minutes from the Bank of Japan show that several members believe a rate hike is needed in the near term, with a roughly 70% probability of an increase in December. Core inflation has met the target for the first time in 30 years, and the current policy rate stands at 1.25%.

智通财经•2026/11/10 03:31
Bank of Japan minutes turn hawkish: Most members believe a rate hike is needed soon, with a 70% probability of a hike in December